Intro the Pharm (Exam 1) Flashcards
(25 cards)
Pharmacology
study of biological effects of chemicals (natural or synthesized)
Drugs
chemicals introduced into the body to cause some type of effect
pharmacotherapeutics (clinical pharmacology)
branch of pharm; uses drugs to treat, prevent, and diagnose disease
2 concerns: drug effect on body, body’s response to drug
Chemical Name
describes a drug’s chemical composition and structure
Generic Name
name given by the United States adopted name Council
Trade Name “brand name”
name given by the drug’s owner or manufacturer; usually carries a registered trademark
Natural Sources of Drugs
Plants-synthetic version of the active chemical found in a plant
animal products-replace human chems loss due to disease or genetic problems
inorganic compounds- salts of various elements can have therapeutic effects in the human body
Clinical Trials
rigorous scientific testing performed to evaluate therapeutic value and toxic effects of potential drugs
tightly controlled by the FDA
Preclinical Trials
chemicals tested on laboratory animals
determines drug-dose range
examines adverse effects
results considered inconclusive
phase I studies
chemicals tested on human volunteers
phase II studies
drug tried on informed patients with the target disease
phase III studies
drugs must pass approval of FDA to enter clinical market
Phase IV studies
continual evaluation of the drug
Pure food and drug act
1906 control labeling
food and drug cosmetic act
1938 procedure for introducing of new drugs; power of enforcement; drug recalls
kefauver-harris act
1965 FDAregulator power-efficacy/safety must be established-result of misuse of thalidomide-helped turn the corner
controlled substance act
1970 defined drug abuse and classification for potential of abuse, restrict drugs with abuse potential, drugs placed into 1 of 5 schedules
orphan drug act
1983 provided incentives for development of drugs to treat rare diseases
tetratogen
substance that has potential to cause defect in an unborn child during pregnancy
teratogen drug classificaition
A: studied in women; no evidence of risk
B: studied in animals; risk unknown for human
C: studied in animals; reveal adverse effects
D: studies: confirmation of fetal risk
X: studies: reveal fetal abnormalities
Drug enforcement administration (DEA)
enforces control
each prescriber has a DEA number-DEA monitors patterns
hospitals and pharmacies must maintain complete records of scheduled drugs
Schedule I (C-I)
high abuse potential and no accepted medical use (heroin, marijuana, LSD)
Schedule II (C-II)
high abuse potential with severe dependence liability (narcotics, amphetamines, and barbiturates)
Schedule III (C-III)
less abuse potential than schedule II drugs and moderate dependence liability (nonbarburate sedatives, nonamphetamine stimulants, limited amounts of certain narcotics)